Thought Leadership
Learning from the world without importing illusions
Why high-performing health systems cannot be copied — and how to learn from them intelligently
Every few years, international rankings reignite the search for a health system worth imitating. The Nordics, the Dutch, Australia, Japan and, in certain eras, the National Health Service, are cast as exemplars of what well-designed systems can achieve. OECD and Commonwealth Fund comparisons highlight familiar patterns: countries with universal coverage, strong primary care and limited financial barriers tend to outperform. The United States remains an outlier, combining the world’s highest spending with persistent unmet need among high-income countries.
These comparisons are informative. But they foster a persistent misconception: that high-performing systems consist of identifiable elements that can be transferred wholesale to other countries. Reformers browse foreign systems as if scanning a catalogue — insurer competition, digital records, co-payment structures, data integration, blended payments — and attempt to import these features into domestic policy.
Health systems are not collections of components. They are equilibria.
They are the product of decades of political choices, institutional development, fiscal strategy and professional culture. What works in one setting often depends less on the instrument itself than on the architecture that holds it in place. Remove that architecture and the same instrument behaves differently.
Consider the Netherlands, frequently cited for its well-regulated managed competition. Individuals purchase insurance from non-profit insurers who compete on price and service under tight state supervision. Risk equalisation is sophisticated; purchasing is disciplined; access remains high. But this model rests on institutional capacities that did not emerge overnight: regulatory depth, a political consensus around solidarity and a payer landscape shaped over decades. Without these foundations, “managed competition” is a slogan rather than a system.
Australia combines universal tax-funded insurance with a regulated private sector, a well-developed general-practice framework and substantial investment in rural access. Its performance on access and outcomes is not the product of one policy lever but of a balancing act between decentralised delivery, a strong national financing spine and a durable political settlement around primary care.
Then there are the non-Western outliers. Singapore achieves long life expectancy at comparatively restrained spending through a layered financing model built on medical savings accounts, subsidised public provision and catastrophic insurance. Taiwan operates a single national insurer with near-universal enrolment and near real-time claim adjudication. These systems are admired globally, but they rely on enabling conditions few countries share: administrative coherence, disciplined incrementalism and high levels of public trust in the stewardship of health financing.
The pattern is consistent. Systems succeed not because of specific design features, but because their features cohere. The pathology of international comparison is to mistake coherence for transferability.
The temptation to imitate is understandable. All countries face similar pressures: rising chronic-disease burden, long-term care demand, workforce shortages and fiscal limits. In such a context, looking abroad feels pragmatic.
But systems do not evolve in a vacuum. They evolve through path dependence, the sequence of political, institutional and social decisions that shape what is possible next. A Beveridge system cannot simply integrate Dutch-style insurer purchasing without altering its constitutional relationship to the state. A Bismarckian system cannot replicate Singapore’s co-payment philosophy without confronting deeply rooted expectations around solidarity. A national insurance model cannot emulate Israel’s digital integration without first overhauling data infrastructure and governance.
Learning from other systems therefore requires structural literacy: the ability to distinguish what is essential to a model’s performance from what is incidental.
Structural literacy begins with context. For any admired feature, one must ask: what conditions enabled it to work? In the Netherlands, regulatory competence and social insurance culture. In Denmark, municipal autonomy combined with national digital standards. In Japan, the integration of long-term care insurance into a broader demographic strategy. In Singapore, the interplay between individual responsibility and strong state subsidies.
Then comes compatibility. Does the importing country possess — or can it build — similar enabling conditions? Many cannot. They may lack administrative capacity, political stability, consistent financing or professional alignment. Without these, imported reforms produce side effects rather than benefits.
Finally comes coherence. A system cannot incorporate isolated reforms without adjusting the rest of its architecture. Introducing DRG payments requires cost literacy and monitoring capacity. Moving to insurer-based purchasing requires a regulatory apparatus capable of steering behaviour. Mandating GP gatekeeping requires primary-care investment and aligned incentives. None of these conditions can be assumed.
This is why health-system tourism, the habit of visiting admired countries and returning with “best practices”, so often disappoints. What is visible abroad is not the system; it is the surface. The real system lies in governance, incentives, information flows, historical expectations and the tacit rules that bind institutions together.
Yet the conclusion should not be pessimistic. International comparison remains valuable, provided it is approached with discipline rather than enthusiasm.
Countries can learn three kinds of lessons:
1
Conceptual lessons:
How different architectures resolve trade-offs between equity, access, financial risk and coordination.
2
Design-principle lessons:
Separating purchasing from provision, aligning incentives with outcomes, building a shared data spine, sequencing reforms gradually.
3
Feasibility lessons:
Recognising what is realistically achievable given domestic politics and institutional capacity.
These lessons do not produce copies. They shape strategy.
The purpose of comparative analysis is not to find “the best system”, but to clarify the kind of system one is trying to build — and the trade-offs one must accept. High performance is always conditional. It is the outcome of choices, constraints and continuities.
Health systems do not need to import foreign features. They need to import foreign questions:
What problem was this reform solving?
Under what conditions did it succeed?
What structural capacities did it require?
Which parts of our system would need to change first?
Most countries do not underperform because they lack good ideas. They underperform because they search for solutions without confronting constraints — political, fiscal, institutional and cultural. Learning from the world is not a matter of policy transfer. It is a matter of institutional honesty.
The systems worth admiring are not those that found perfect answers. They are those that built enduring coherence, reflected in clarity of architecture, stability of governance and discipline of execution.
International comparison is valuable when it deepens structural understanding rather than encouraging imitation. The question is not which system to copy, but which institutional conditions must be strengthened to make reform durable.
Learning from the world is not about importing solutions. It is about clarifying what one’s own system must become.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.